Steroid Hormone Receptor Coregulators in Endocrine Cancers
Related Experiment Video
Updated: Mar 20, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Jean-Pierre Obeid1, Nawal Zafar1, Jimmy El Hokayem1
1Department of Biochemistry and Molecular Biology, University of Miami, FL, USA.
Abstract:
Coregulators span a broad and extensive domain in modulating cellular transcriptional activity. Studies have established a dynamic role for such coregulators in various endocrine cancers. Steroid hormone receptors (SHRs) play a pivotal role in such endocrine cancers, and interact abundantly with transcriptional coregulators in altering gene expression. Several families of coregulators have implications in propagating the development, progression and invasion of breast, prostate, and other hormone-responsive cancers. This mini-review aims to discuss different classes of coregulators involved in endocrine cancers and highlight unique information regarding each family with relevance to mechanism, intervention, and novel directions being investigated. © 2016 IUBMB Life, 68(7):504-515, 2016.
Insights
Transcriptional coregulators are key players in endocrine cancers, influencing gene expression through interactions with steroid hormone receptors. This review details coregulator classes, their mechanisms, and therapeutic potential in hormone-responsive cancers.
Area of Science:
- Molecular Biology
- Endocrinology
- Cancer Research
Background:
- Coregulators dynamically modulate cellular transcriptional activity.
- Steroid hormone receptors (SHRs) are pivotal in endocrine cancers, interacting with coregulators to alter gene expression.
- Coregulator families are implicated in the development, progression, and invasion of hormone-responsive cancers.
Purpose of the Study:
- To review different classes of coregulators involved in endocrine cancers.
- To highlight unique information regarding each coregulator family.
- To discuss mechanisms, interventions, and novel research directions for coregulators in endocrine cancers.
Main Methods:
- This mini-review synthesizes existing literature on coregulators in endocrine cancers.
- It focuses on the roles of various coregulator families.
- Information is presented regarding mechanisms, therapeutic interventions, and future research avenues.
Main Results:
- Coregulators exhibit diverse roles in transcriptional regulation within endocrine cancers.
- Specific coregulator families have distinct implications in cancer development and progression.
- Understanding these interactions offers potential for novel therapeutic strategies.
Conclusions:
- Coregulators are critical modulators of gene expression in endocrine cancers.
- Targeting coregulator pathways presents a promising avenue for cancer intervention.
- Further research into coregulator mechanisms and novel directions is essential for advancing treatment.
More Related Videos
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
09:00An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles
Published on: March 18, 2015
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Endocrine Signaling
Endocrine Signaling
Intracellular Hormone Receptors
Co-activators and Co-repressors